You are here

  • Home
  • Archive
  • Volume 9, Issue 11
  • Selective IL-1 activity on CD8+ T cells empowers antitumor immunity and synergizes with neovasculature-targeted TNF for full tumor eradication

Article metrics

Article menu
Clinical/translational cancer immunotherapy
Original research
Selective IL-1 activity on CD8+ T cells empowers antitumor immunity and synergizes with neovasculature-targeted TNF for full tumor eradication

 

Online download statistics by month:

Online download statistics by month: November 2021 to July 2025

AbstractFullPdf
Nov 2021661664268
Dec 202127427888
Jan 202212412650
Feb 2022687439
Mar 2022848743
Apr 2022929341
May 202213914537
Jun 202213113517
Jul 2022757729
Aug 2022929827
Sep 202210811433
Oct 2022889442
Nov 2022525215
Dec 2022474715
Jan 2023555734
Feb 2023697016
Mar 2023454616
Apr 202329318
May 2023424427
Jun 2023555526
Jul 2023575717
Aug 2023424213
Sep 2023495019
Oct 2023515220
Nov 2023737521
Dec 2023565814
Jan 202424255
Feb 2024697120
Mar 20249410163
Apr 2024656526
May 2024768223
Jun 2024697124
Jul 202412713728
Aug 2024666819
Sep 2024697016
Oct 2024697024
Nov 2024616734
Dec 20249610136
Jan 2025777830
Feb 2025838338
Mar 2025484824
Apr 2025848467
May 2025737332
Jun 2025364125
Jul 2025110
Total394540571509